Very solid business with huge upside. 8mil market cap. It should be 5 to 10 times the current value easily.
Other AIM oncology stocks trade at x 25 to x 50 annual revenues
I initially read EV/EBITDA of 6.5… big difference 
. (Unless the profit margins are very high)